Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2020-12-21 Sale | 2020-12-22 5:49 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Schwabe Stefan K.F. Executive Vice President & CMO | 46,347 | $22.1 | $1,024,463 | 2,772 (Direct) | View |
| 2020-12-14 Sale | 2020-12-15 8:20 pm | SUPERNUS PHARMACEUTICALS INC. | SUPN | Schwabe Stefan K.F. Executive Vice President & CMO | 53,653 | $21.87 | $1,173,264 | 49,119 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2020-12-21 Exercise | 2020-12-22 5:49 pm | N/A 2026-03-01 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Schwabe Stefan K.F. Executive Vice President & CMO | 46,347 | $0 | 2,772 (Direct) | View |
| 2020-12-21 Exercise | 2020-12-22 5:49 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Schwabe Stefan K.F. Executive Vice President & CMO | 46,347 | $12.98 | 2,772 (Direct) | View |
| 2020-12-14 Exercise | 2020-12-15 8:20 pm | N/A 2025-03-03 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Schwabe Stefan K.F. Executive Vice President & CMO | 53,653 | $0 | 49,119 (Direct) | View |
| 2020-12-14 Exercise | 2020-12-15 8:20 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Schwabe Stefan K.F. Executive Vice President & CMO | 50,000 | $9.13 | 49,119 (Direct) | View |
| 2020-12-14 Exercise | 2020-12-15 8:20 pm | N/A N/A | SUPERNUS PHARMACEUTICALS INC. | SUPN | Schwabe Stefan K.F. Executive Vice President & CMO | 3,653 | $12.98 | 49,119 (Direct) | View |
| 2020-02-21 Option Award | 2020-02-25 5:24 pm | N/A 2030-02-21 | SUPERNUS PHARMACEUTICALS INC. | SUPN | Schwabe Stefan K.F. Executive Vice President & CMO | 50,000 | $0 | 52,772 (Direct) | View |